摘要:
Substituted diphenylamine compounds of general formula I are provided, in which each substituted group is defined as in the description. The compounds of general formula I have broad-spectrum fungicidal activity in the field of agriculture. Furthermore, the preparation methods of the above compounds are simple.
摘要:
Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of p53 in K-Ras mutant cell lines, thereby enabling effective treatment or prevention of K-Ras mutant cancer, such as, pancreatic cancer, lung cancer, cholangioma, and colon cancer, of which diagnosis or treatment is not easy.
摘要:
A novel 3-triazolylphenyl sulfide derivative which has excellent soil treatment activity when used as an insecticide/acaricide/nematicide for agricultural or horticultural plants. It is a 3-triazolylphenyl sulfide derivative represented by the general formula [I]: (wherein R represents cyclopropylmethyl or trifluoroethyl; B2 represents hydrogen, halogeno, or methyl; B4 represents halogeno, cyano, nitro, or C1-6 alkyl; and A1 and A3 each represents hydrogen, halogeno, optionally substituted C1-6 alkyl, or optionally substituted amino).
摘要:
The invention relates to certain 2-substituted phenoxyacetic acid derivatives of formula (I), in which the variables are as defined in the claims, useful in the treatment of diseases or conditions in which modulation of the CRTh2 receptor is beneficial, such as asthma and rhinitis.
摘要:
There are disclosed compounds of the formula (I) a pharmaceutically acceptable salt or solvate of the compound, which exhibit anti-inflammatory and immunomodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds.
摘要:
This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds. The claimed compounds have prostaglandin G/H synthase inhibitor activity and are suitable for the treatment of inflammatory diseases, such as myositis, synovitis, rheumatoid arthritis, osteoarthritis, gout, ankylosing spondylitis and bursitis, for the treatment of Alzheimer's disease or of an autoimmune disease such as systemic lupus erythematosus and type I diabetes.
摘要:
A process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene sulfonyl chlorides of the formula (I), in which R is alkyl or aryl substituted at the ortho or meta positions with alkyl, aryl, NHAc or alkoxy, comprising the steps of: a) reacting 2-chloronitrobenzene, 2-fluoronitrobenzene or 2-bromonitrobenzene with a compound of the following formula: RSO2-M+ wherein R is defined above; and M is sodium, potassium, lithium, ammonium or quaternary ammonium, in a polar aprotic solvent at a temperature of about 50 to 190°C; b) reacting the material prepared in step (a) with hydrogen at a pressure of about 20 to about 60 psi in a polar aprotic solvent at a temperature of about 20 to about 60°C; and c) diazotizing the material prepared in step (b) with sodium nitrite in the presence of hydrochloric acid and reacting the resulting diazonium salt with sulfur dioxide in the presence of copper (I) or copper (II) compounds or a mixture thereof, in water.
摘要:
The invention concerns a method for the condensation of aromatic derivative(s) or a sulphinic derivative by a perhalogenated, advantageously perfluorinated, carbon atom. Said method is characterised in that it consists in subjecting said sulphinic derivative and said aromatic derivative to the action of a strong acid whereof the pKa is not more than 0. The invention is applicable to organic synthesis.
摘要:
Sulfonyl compounds of formula (I) in which n is 0, 1 or 2; Y is vinyl or a radical of the formula C2H4Q, where Q is hydroxy or a group separable in alkaline reaction conditions; E is C3-C6 alkylene which may be interrupted by 1 or 2 oxygen atoms in the ether function; Ar is the radical of benzole or naphthalene; and R , R and R are hydrogen, possibly substituted C1-C6 alkyl, C1-C6 alkoxy, hydroxy, halogen, nitro, possibly substituted amino, hydroxysulphonyl, carboxyl, possibly substituted carbamoyl, possibly substituted sulphamoyl, cyano or a radical of the formula (NH-)m(CH2)qSO2-Y, where m is 0 or 1 and q is 0, 2 or 3 and Y has the meaning given above.
摘要:
The present invention relates to novel compounds of the general formula wherein
R 1 is hydrogen; R 2 is hydrogen, trifluoromethyl or lower alkyl; R 3 is hydrogen or amino; or R 1 and R 2 or R 3 and R 2 taken together are -CH=CH-CH=CH-; Z is pyrimidin-4-yl, pyridin-4-yl, pyridin-2-yl or phenyl; R 4, R 5 are each independently hydrogen, lower alkyl, trifluoromethyl, halogen, lower alkoxy, nitrilo, amino, lower alkyl-amino, di-lower alkyl-amino, piperazinyl, morpholinyl, pyrrolidinyl, vinyl, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkenyl, t-buthylethinyl, hydroxyalkylethinyl, phenylethinyl, naphthyl, thiophenyl, or phenyl, which may be substituted by halogen, lower alkoxy, lower alkyl, trifluoromethyl or nitro, or a group -NH(CH 2 ) n NR 6 R 7 , -N(CH 3 )(CH 2 ) n NR 6 R 7 , -NH(CH 2 ) n -morpholin-4-yl or -NH(CH 2 ) n OH; n is 2-4 R 6 and R 7 are each independently hydrogen or lower alkyl, and to their pharmaceutically acceptable salts.
It has been found that the compounds of formula I possess a selective affinity to 5HT-6 receptors.
摘要翻译:本发明涉及通式的新化合物,其中R 1是氢; R 2是氢,三氟甲基或低级烷基; R 3是氢或氨基; 或R 1和R 2或R 3和R 2一起是-CH = CH-CH = CH-; Z是嘧啶-4-基,吡啶-4-基,吡啶-2-基或苯基; R 4,R 5各自独立地为氢,低级烷基,三氟甲基,卤素,低级烷氧基,次氮基,氨基,低级烷基 - 氨基,二低级烷基 - 氨基,哌嗪基,吗啉基,吡咯烷基,乙烯基, C 6环烷基,C 3 -C 6环烯基,叔丁基乙酰基,羟基烷基乙烯基,苯乙酰基,萘基,噻吩基或苯基,其可以被卤素,低级烷氧基,低级烷基,三氟甲基或硝基取代,或基团-NH(CH 2)n NR (CH 3)(CH 2)n NR 6 R 7,-NH(CH 2)n - 吗啉-4-基或-NH(CH 2)n OH; n是2-4 R 6和R 7各自独立地是氢或低级烷基,以及它们的药学上可接受的盐。 已经发现,式I化合物对5HT-6受体具有选择性亲和力。